Compare MRAM & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRAM | SEER |
|---|---|---|
| Founded | 2008 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 353.8M | 108.0M |
| IPO Year | 2016 | 2020 |
| Metric | MRAM | SEER |
|---|---|---|
| Price | $14.61 | $1.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $18.50 | N/A |
| AVG Volume (30 Days) | ★ 956.1K | 151.1K |
| Earning Date | 04-29-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.40 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $49,417,000.00 | $16,578,000.00 |
| Revenue This Year | $10.22 | $2.14 |
| Revenue Next Year | $7.38 | $25.90 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 37.51 | 16.99 |
| 52 Week Low | $7.35 | $1.55 |
| 52 Week High | $51.50 | $2.41 |
| Indicator | MRAM | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 39.22 | 35.64 |
| Support Level | $13.17 | $1.83 |
| Resistance Level | $15.93 | $1.94 |
| Average True Range (ATR) | 0.91 | 0.04 |
| MACD | -0.11 | -0.01 |
| Stochastic Oscillator | 1.66 | 5.52 |
Everspin Technologies Inc is a manufacturer of Magnetoresistive Random Access Memory (MRAM) technology. The company manufactures MRAM products using both captive and third-party manufacturing capabilities. It purchases industry-standard complementary metal-oxide semiconductor (CMOS) wafers from semiconductor foundries and perform back end of line (BEOL) processing that includes magnetic-bit technology at leased 200mm fabrication facility in Chandler, Arizona. It also manufactures full-flow 300mm CMOS wafers with STT-MRAM magnetic-bit technology integrated in BEOL. The company's customers are in key markets, such as industrial, medical, automotive/transportation, aerospace, and data center.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.